ID   DHE3_HUMAN              Reviewed;         558 AA.
AC   P00367; B3KV55; B4DGN5; Q5TBU3;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 2.
DT   10-MAY-2017, entry version 198.
DE   RecName: Full=Glutamate dehydrogenase 1, mitochondrial;
DE            Short=GDH 1;
DE            EC=1.4.1.3;
DE   Flags: Precursor;
GN   Name=GLUD1; Synonyms=GLUD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Liver;
RX   PubMed=3426581; DOI=10.1016/0006-291X(87)90381-0;
RA   Nakatani Y., Banner C., von Herrat M., Schneider M.E., Smith H.H.,
RA   Freese E.;
RT   "Comparison of human brain and liver glutamate dehydrogenase cDNAs.";
RL   Biochem. Biophys. Res. Commun. 149:405-410(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3377777; DOI=10.1016/S0006-291X(88)80440-6;
RA   Amuro N., Yamaura M., Goto Y., Okazaki T.;
RT   "Molecular cloning and nucleotide sequence of the cDNA for human liver
RT   glutamate dehydrogenase precursor.";
RL   Biochem. Biophys. Res. Commun. 152:1395-1400(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3399399; DOI=10.1093/nar/16.13.6237;
RA   Nakatani Y., Schneider M.E., Banner C., Freese E.;
RT   "Complete nucleotide sequence of human glutamate dehydrogenase cDNA.";
RL   Nucleic Acids Res. 16:6237-6237(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3368458; DOI=10.1073/pnas.85.10.3494;
RA   Mavrothalassitis G., Tzimagiorgis G., Mitsialis A., Zannis V.,
RA   Plaitakis A., Papamatheakis J., Moschonas N.;
RT   "Isolation and characterization of cDNA clones encoding human liver
RT   glutamate dehydrogenase: evidence for a small gene family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:3494-3498(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8486350; DOI=10.1006/geno.1993.1152;
RA   Michaelidis T.M., Tzimagiorgis G., Moschonas N.K., Papamatheakis J.;
RT   "The human glutamate dehydrogenase gene family: gene organization and
RT   structural characterization.";
RL   Genomics 16:150-160(1993).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain, and Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Duodenum, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 54-558.
RC   TISSUE=Liver;
RX   PubMed=429360;
RA   Julliard J.H., Smith E.L.;
RT   "Partial amino acid sequence of the glutamate dehydrogenase of human
RT   liver and a revision of the sequence of the bovine enzyme.";
RL   J. Biol. Chem. 254:3427-3438(1979).
RN   [11]
RP   PROTEIN SEQUENCE OF 54-69.
RC   TISSUE=Liver;
RX   PubMed=1286669; DOI=10.1002/elps.11501301201;
RA   Hochstrasser D.F., Frutiger S., Paquet N., Bairoch A., Ravier F.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Bjellqvist B., Vargas R.,
RA   Appel R.D., Hughes G.J.;
RT   "Human liver protein map: a reference database established by
RT   microsequencing and gel comparison.";
RL   Electrophoresis 13:992-1001(1992).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 301-558 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=3585334; DOI=10.1111/j.1471-4159.1987.tb03422.x;
RA   Banner C., Silverman S., Thomas J.W., Lampel K.A., Vitkovic L.,
RA   Huie D., Wenthold R.J.;
RT   "Isolation of a human brain cDNA for glutamate dehydrogenase.";
RL   J. Neurochem. 49:246-252(1987).
RN   [13]
RP   PROTEIN SEQUENCE OF 481-496, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Vishwanath V.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 540-558.
RX   PubMed=8314555; DOI=10.1007/BF00217767;
RA   Tzimagiorgis G., Leversha M.A., Chroniary K., Goulielmos G.,
RA   Sargent C.A., Ferguson-Smith M., Moschonas N.K.;
RT   "Structure and expression analysis of a member of the human glutamate
RT   dehydrogenase (GLUD) gene family mapped to chromosome 10p11.2.";
RL   Hum. Genet. 91:433-438(1993).
RN   [15]
RP   ADP-RIBOSYLATION AT CYS-172.
RX   PubMed=16023112; DOI=10.1016/j.febslet.2005.06.041;
RA   Choi M.M., Huh J.W., Yang S.J., Cho E.H., Choi S.Y., Cho S.W.;
RT   "Identification of ADP-ribosylation site in human glutamate
RT   dehydrogenase isozymes.";
RL   FEBS Lett. 579:4125-4130(2005).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-84; LYS-480 AND LYS-503, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-227; SER-384 AND
RP   TYR-512, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER TYR-53, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   CHARACTERIZATION OF VARIANT TYR-507, AND ALLOSTERIC REGULATION.
RX   PubMed=11254391; DOI=10.1006/jmbi.2001.4499;
RA   Smith T.J., Peterson P.E., Schmidt T., Fang J., Stanley C.A.;
RT   "Structures of bovine glutamate dehydrogenase complexes elucidate the
RT   mechanism of purine regulation.";
RL   J. Mol. Biol. 307:707-720(2001).
RN   [21]
RP   MUTAGENESIS OF SER-501 AND ARG-516, CHARACTERIZATION OF VARIANT
RP   TYR-507, AND ALLOSTERIC REGULATION.
RX   PubMed=11903050; DOI=10.1042/0264-6021:3630081;
RA   Fang J., Hsu B.Y.L., MacMullen C.M., Poncz M., Smith T.J.,
RA   Stanley C.A.;
RT   "Expression, purification and characterization of human glutamate
RT   dehydrogenase (GDH) allosteric regulatory mutations.";
RL   Biochem. J. 363:81-87(2002).
RN   [22]
RP   ADP-RIBOSYLATION.
RX   PubMed=16959573; DOI=10.1016/j.cell.2006.06.057;
RA   Haigis M.C., Mostoslavsky R., Haigis K.M., Fahie K.,
RA   Christodoulou D.C., Murphy A.J., Valenzuela D.M., Yancopoulos G.D.,
RA   Karow M., Blander G., Wolberger C., Prolla T.A., Weindruch R.,
RA   Alt F.W., Guarente L.;
RT   "SIRT4 inhibits glutamate dehydrogenase and opposes the effects of
RT   calorie restriction in pancreatic beta cells.";
RL   Cell 126:941-954(2006).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 54-558.
RX   PubMed=12054821; DOI=10.1016/S0022-2836(02)00161-4;
RA   Smith T.J., Schmidt T., Fang J., Wu J., Siuzdak G., Stanley C.A.;
RT   "The structure of apo human glutamate dehydrogenase details subunit
RT   communication and allostery.";
RL   J. Mol. Biol. 318:765-777(2002).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 63-558 OF MUTANT ALA-516, AND
RP   ALLOSTERIC REGULATION.
RX   PubMed=12653548; DOI=10.1021/bi0206917;
RA   Banerjee S., Schmidt T., Fang J., Stanley C.A., Smith T.J.;
RT   "Structural studies on ADP activation of mammalian glutamate
RT   dehydrogenase and the evolution of regulation.";
RL   Biochemistry 42:3446-3456(2003).
RN   [25]
RP   REVIEW ON VARIANTS.
RX   PubMed=10338089;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:5<351::AID-HUMU3>3.0.CO;2-R;
RA   Meissner T., Beinbrech B., Mayatepek E.;
RT   "Congenital hyperinsulinism: molecular basis of a heterogeneous
RT   disease.";
RL   Hum. Mutat. 13:351-361(1999).
RN   [26]
RP   VARIANTS HHF6 LEU-498; SER-499; ASP-499; PRO-501 AND TYR-507.
RX   PubMed=9571255; DOI=10.1056/NEJM199805073381904;
RA   Stanley C.A., Lieu Y.K., Hsu B.Y.L., Burlina A.B., Greenberg C.R.,
RA   Hopwood N.J., Perlman K., Rich B.H., Zammarchi E., Poncz M.;
RT   "Hyperinsulinism and hyperammonemia in infants with regulatory
RT   mutations of the glutamate dehydrogenase gene.";
RL   N. Engl. J. Med. 338:1352-1357(1998).
RN   [27]
RP   VARIANTS HHF6 LYS-318 AND ALA-349.
RX   PubMed=10636977; DOI=10.1016/S0022-3476(00)90052-0;
RA   Miki Y., Taki T., Ohura T., Kato H., Yanagisawa M., Hayashi Y.;
RT   "Novel missense mutations in the glutamate dehydrogenase gene in the
RT   congenital hyperinsulinism-hyperammonemia syndrome.";
RL   J. Pediatr. 136:69-72(2000).
RN   [28]
RP   VARIANTS HHF6 CYS-274 AND HIS-322.
RX   PubMed=11214910; DOI=10.1007/s004390000432;
RA   Santer R., Kinner M., Passarge M., Superti-Furga A., Mayatepek E.,
RA   Meissner T., Schneppenheim R., Schaub J.;
RT   "Novel missense mutations outside the allosteric domain of glutamate
RT   dehydrogenase are prevalent in European patients with the congenital
RT   hyperinsulinism-hyperammonemia syndrome.";
RL   Hum. Genet. 108:66-71(2001).
RN   [29]
RP   VARIANTS HHF6 CYS-270; CYS-274; THR-318; CYS-319; CYS-322 AND HIS-322.
RX   PubMed=11297618; DOI=10.1210/jcem.86.4.7414;
RA   MacMullen C., Fang J., Hsu B.Y.L., Kelly A., de Lonlay-Debeney P.,
RA   Saudubray J.-M., Ganguly A., Smith T.J., Stanley C.A., Brown R.,
RA   Buist N., Dasouki M., Fefferman R., Grange D., Karaviti L., Luedke C.,
RA   Marriage B., McLaughlin J., Perlman K., Seashore M., van Vliet G.;
RT   "Hyperinsulinism/hyperammonemia syndrome in children with regulatory
RT   mutations in the inhibitory guanosine triphosphate-binding domain of
RT   glutamate dehydrogenase.";
RL   J. Clin. Endocrinol. Metab. 86:1782-1787(2001).
CC   -!- FUNCTION: Mitochondrial glutamate dehydrogenase that converts L-
CC       glutamate into alpha-ketoglutarate. Plays a key role in glutamine
CC       anaplerosis by producing alpha-ketoglutarate, an important
CC       intermediate in the tricarboxylic acid cycle. May be involved in
CC       learning and memory reactions by increasing the turnover of the
CC       excitatory neurotransmitter glutamate (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: L-glutamate + H(2)O + NAD(P)(+) = 2-
CC       oxoglutarate + NH(3) + NAD(P)H. {ECO:0000255|PROSITE-
CC       ProRule:PRU10011}.
CC   -!- ENZYME REGULATION: Subject to allosteric regulation. Activated by
CC       ADP. Inhibited by GTP and ATP. ADP can occupy the NADH binding
CC       site and activate the enzyme.
CC   -!- SUBUNIT: Homohexamer.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P00367-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P00367-2; Sequence=VSP_056244;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P00367-3; Sequence=VSP_056523, VSP_056524;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: ADP-ribosylated by SIRT4, leading to inactivate glutamate
CC       dehydrogenase activity (By similarity). Stoichiometry shows that
CC       ADP-ribosylation occurs in one subunit per catalytically active
CC       homohexamer. {ECO:0000250}.
CC   -!- DISEASE: Familial hyperinsulinemic hypoglycemia 6 (HHF6)
CC       [MIM:606762]: Familial hyperinsulinemic hypoglycemia [MIM:256450],
CC       also referred to as congenital hyperinsulinism, nesidioblastosis,
CC       or persistent hyperinsulinemic hypoglycemia of infancy (PPHI), is
CC       the most common cause of persistent hypoglycemia in infancy and is
CC       due to defective negative feedback regulation of insulin secretion
CC       by low glucose levels. In HHF6 elevated oxidation rate of
CC       glutamate to alpha-ketoglutarate stimulates insulin secretion in
CC       the pancreatic beta cells, while they impair detoxification of
CC       ammonium in the liver. {ECO:0000269|PubMed:10636977,
CC       ECO:0000269|PubMed:11214910, ECO:0000269|PubMed:11297618,
CC       ECO:0000269|PubMed:9571255}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Glu/Leu/Phe/Val dehydrogenases family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Glutamate dehydrogenase 1
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Glutamate_dehydrogenase_1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X07674; CAA30521.1; -; mRNA.
DR   EMBL; M20867; AAA52526.1; -; mRNA.
DR   EMBL; M37154; AAA52525.1; -; mRNA.
DR   EMBL; X07769; CAA30598.1; -; mRNA.
DR   EMBL; J03248; AAA52523.1; -; mRNA.
DR   EMBL; X66300; CAA46994.2; -; Genomic_DNA.
DR   EMBL; X66301; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66302; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66303; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66304; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66305; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66306; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66307; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66308; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66309; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66311; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; X66312; CAA46994.2; JOINED; Genomic_DNA.
DR   EMBL; AK122685; BAG53667.1; -; mRNA.
DR   EMBL; AK294685; BAG57846.1; -; mRNA.
DR   EMBL; AL136982; CAI17120.1; -; Genomic_DNA.
DR   EMBL; CH471142; EAW80300.1; -; Genomic_DNA.
DR   EMBL; CH471142; EAW80302.1; -; Genomic_DNA.
DR   EMBL; BC040132; AAH40132.1; -; mRNA.
DR   EMBL; BC112946; AAI12947.1; -; mRNA.
DR   EMBL; X67491; CAA47830.1; -; Genomic_DNA.
DR   CCDS; CCDS7382.1; -. [P00367-1]
DR   PIR; A28208; DEHUE.
DR   PIR; I37424; I37424.
DR   PIR; S29331; S29331.
DR   PIR; S60192; S60192.
DR   RefSeq; NP_001305829.1; NM_001318900.1. [P00367-3]
DR   RefSeq; NP_001305830.1; NM_001318901.1. [P00367-2]
DR   RefSeq; NP_001305831.1; NM_001318902.1. [P00367-2]
DR   RefSeq; NP_001305833.1; NM_001318904.1. [P00367-2]
DR   RefSeq; NP_001305834.1; NM_001318905.1. [P00367-2]
DR   RefSeq; NP_001305835.1; NM_001318906.1. [P00367-2]
DR   RefSeq; NP_005262.1; NM_005271.4. [P00367-1]
DR   UniGene; Hs.500409; -.
DR   UniGene; Hs.731740; -.
DR   PDB; 1L1F; X-ray; 2.70 A; A/B/C/D/E/F=54-558.
DR   PDB; 1NR1; X-ray; 3.30 A; A/B/C/D/E/F=63-558.
DR   PDBsum; 1L1F; -.
DR   PDBsum; 1NR1; -.
DR   ProteinModelPortal; P00367; -.
DR   SMR; P00367; -.
DR   BioGrid; 109008; 38.
DR   IntAct; P00367; 32.
DR   MINT; MINT-5005913; -.
DR   STRING; 9606.ENSP00000277865; -.
DR   DrugBank; DB04137; Guanosine-5'-Triphosphate.
DR   DrugBank; DB00756; Hexachlorophene.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; P00367; -.
DR   PhosphoSitePlus; P00367; -.
DR   SwissPalm; P00367; -.
DR   BioMuta; GLUD1; -.
DR   DMDM; 118541; -.
DR   REPRODUCTION-2DPAGE; IPI00016801; -.
DR   SWISS-2DPAGE; P00367; -.
DR   UCD-2DPAGE; P00367; -.
DR   EPD; P00367; -.
DR   MaxQB; P00367; -.
DR   PaxDb; P00367; -.
DR   PeptideAtlas; P00367; -.
DR   PRIDE; P00367; -.
DR   Ensembl; ENST00000277865; ENSP00000277865; ENSG00000148672. [P00367-1]
DR   GeneID; 2746; -.
DR   KEGG; hsa:2746; -.
DR   UCSC; uc001keh.4; human. [P00367-1]
DR   CTD; 2746; -.
DR   DisGeNET; 2746; -.
DR   GeneCards; GLUD1; -.
DR   GeneReviews; GLUD1; -.
DR   HGNC; HGNC:4335; GLUD1.
DR   HPA; HPA042492; -.
DR   HPA; HPA044839; -.
DR   HPA; HPA061369; -.
DR   MalaCards; GLUD1; -.
DR   MIM; 138130; gene.
DR   MIM; 606762; phenotype.
DR   neXtProt; NX_P00367; -.
DR   OpenTargets; ENSG00000148672; -.
DR   Orphanet; 35878; Hyperinsulinism-hyperammonemia syndrome.
DR   PharmGKB; PA28737; -.
DR   eggNOG; KOG2250; Eukaryota.
DR   eggNOG; COG0334; LUCA.
DR   GeneTree; ENSGT00390000000854; -.
DR   HOGENOM; HOG000243801; -.
DR   HOVERGEN; HBG005479; -.
DR   InParanoid; P00367; -.
DR   KO; K00261; -.
DR   OMA; YMSMIGT; -.
DR   OrthoDB; EOG091G0KMT; -.
DR   PhylomeDB; P00367; -.
DR   TreeFam; TF313945; -.
DR   BioCyc; MetaCyc:HS07548-MONOMER; -.
DR   BRENDA; 1.4.1.3; 2681.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   SABIO-RK; P00367; -.
DR   SIGNOR; P00367; -.
DR   ChiTaRS; GLUD1; human.
DR   EvolutionaryTrace; P00367; -.
DR   GeneWiki; Glutamate_dehydrogenase_1; -.
DR   GenomeRNAi; 2746; -.
DR   PRO; PR:P00367; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148672; -.
DR   CleanEx; HS_GLUD1; -.
DR   ExpressionAtlas; P00367; baseline and differential.
DR   Genevisible; P00367; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043531; F:ADP binding; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004352; F:glutamate dehydrogenase (NAD+) activity; IDA:UniProtKB.
DR   GO; GO:0004353; F:glutamate dehydrogenase [NAD(P)+] activity; IDA:BHF-UCL.
DR   GO; GO:0005525; F:GTP binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; TAS:BHF-UCL.
DR   GO; GO:0070728; F:leucine binding; IDA:BHF-UCL.
DR   GO; GO:0070403; F:NAD+ binding; IDA:BHF-UCL.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006537; P:glutamate biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0006538; P:glutamate catabolic process; IDA:UniProtKB.
DR   GO; GO:0006541; P:glutamine metabolic process; ISS:UniProtKB.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:BHF-UCL.
DR   GO; GO:0021762; P:substantia nigra development; IEP:UniProtKB.
DR   GO; GO:0072350; P:tricarboxylic acid metabolic process; ISS:UniProtKB.
DR   CDD; cd01076; NAD_bind_1_Glu_DH; 1.
DR   InterPro; IPR006095; Glu/Leu/Phe/Val_DH.
DR   InterPro; IPR033524; Glu/Leu/Phe/Val_DH_AS.
DR   InterPro; IPR006096; Glu/Leu/Phe/Val_DH_C.
DR   InterPro; IPR006097; Glu/Leu/Phe/Val_DH_dimer_dom.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR033922; NAD_bind_Glu_DH.
DR   Pfam; PF00208; ELFV_dehydrog; 1.
DR   Pfam; PF02812; ELFV_dehydrog_N; 1.
DR   PRINTS; PR00082; GLFDHDRGNASE.
DR   SMART; SM00839; ELFV_dehydrog; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00074; GLFV_DEHYDROGENASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ADP-ribosylation; Alternative splicing;
KW   ATP-binding; Complete proteome; Direct protein sequencing;
KW   Disease mutation; GTP-binding; Mitochondrion; NADP;
KW   Nucleotide-binding; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1     53       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:1286669,
FT                                ECO:0000269|PubMed:429360}.
FT   CHAIN        54    558       Glutamate dehydrogenase 1, mitochondrial.
FT                                /FTId=PRO_0000007206.
FT   NP_BIND     141    143       NAD. {ECO:0000250}.
FT   ACT_SITE    183    183
FT   BINDING     147    147       Substrate. {ECO:0000250}.
FT   BINDING     171    171       Substrate. {ECO:0000250}.
FT   BINDING     176    176       NAD. {ECO:0000250}.
FT   BINDING     252    252       NAD. {ECO:0000250}.
FT   BINDING     266    266       GTP. {ECO:0000250}.
FT   BINDING     270    270       GTP. {ECO:0000250}.
FT   BINDING     319    319       GTP. {ECO:0000250}.
FT   BINDING     322    322       GTP. {ECO:0000250}.
FT   BINDING     438    438       Substrate. {ECO:0000250}.
FT   BINDING     444    444       NAD. {ECO:0000250}.
FT   BINDING     450    450       ADP. {ECO:0000250}.
FT   BINDING     516    516       ADP. {ECO:0000250}.
FT   MOD_RES      68     68       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES      79     79       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES      84     84       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      84     84       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     110    110       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     110    110       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     128    128       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     135    135       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     162    162       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     162    162       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     171    171       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     172    172       ADP-ribosylcysteine.
FT                                {ECO:0000269|PubMed:16023112}.
FT   MOD_RES     183    183       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     183    183       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     187    187       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     191    191       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     191    191       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     200    200       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     211    211       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     227    227       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     326    326       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     346    346       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     346    346       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     352    352       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     352    352       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     363    363       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     363    363       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     365    365       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     365    365       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     384    384       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     386    386       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     390    390       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     390    390       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     399    399       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     410    410       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P10860}.
FT   MOD_RES     415    415       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     415    415       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     457    457       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     457    457       N6-malonyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES     457    457       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     477    477       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     477    477       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     480    480       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     480    480       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   MOD_RES     503    503       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     503    503       N6-malonyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES     503    503       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     512    512       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     527    527       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     527    527       N6-malonyllysine; alternate.
FT                                {ECO:0000250}.
FT   MOD_RES     527    527       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     545    545       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     545    545       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P00366}.
FT   MOD_RES     548    548       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P26443}.
FT   VAR_SEQ       1    167       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056244.
FT   VAR_SEQ       1     16       MYRYLGEALLLSRAGP -> MTCPCDNASSVFLGFC (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056523.
FT   VAR_SEQ      17    149       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056524.
FT   VARIANT     270    270       S -> C (in HHF6; diminished sensitivity
FT                                to GTP). {ECO:0000269|PubMed:11297618}.
FT                                /FTId=VAR_016760.
FT   VARIANT     274    274       R -> C (in HHF6; diminished sensitivity
FT                                to GTP; dbSNP:rs56275071).
FT                                {ECO:0000269|PubMed:11214910,
FT                                ECO:0000269|PubMed:11297618}.
FT                                /FTId=VAR_016761.
FT   VARIANT     318    318       R -> K (in HHF6; dbSNP:rs121909736).
FT                                {ECO:0000269|PubMed:10636977}.
FT                                /FTId=VAR_009270.
FT   VARIANT     318    318       R -> T (in HHF6; diminished sensitivity
FT                                to GTP). {ECO:0000269|PubMed:11297618}.
FT                                /FTId=VAR_016762.
FT   VARIANT     319    319       Y -> C (in HHF6).
FT                                {ECO:0000269|PubMed:11297618}.
FT                                /FTId=VAR_016763.
FT   VARIANT     322    322       R -> C (in HHF6; diminished sensitivity
FT                                to GTP). {ECO:0000269|PubMed:11297618}.
FT                                /FTId=VAR_016764.
FT   VARIANT     322    322       R -> H (in HHF6; diminished sensitivity
FT                                to GTP; dbSNP:rs121909737).
FT                                {ECO:0000269|PubMed:11214910,
FT                                ECO:0000269|PubMed:11297618}.
FT                                /FTId=VAR_016765.
FT   VARIANT     349    349       E -> A (in HHF6; dbSNP:rs121909735).
FT                                {ECO:0000269|PubMed:10636977}.
FT                                /FTId=VAR_009271.
FT   VARIANT     498    498       S -> L (in HHF6; dbSNP:rs121909731).
FT                                {ECO:0000269|PubMed:9571255}.
FT                                /FTId=VAR_008666.
FT   VARIANT     499    499       G -> D (in HHF6; dbSNP:rs121909734).
FT                                {ECO:0000269|PubMed:9571255}.
FT                                /FTId=VAR_008667.
FT   VARIANT     499    499       G -> S (in HHF6; dbSNP:rs121909733).
FT                                {ECO:0000269|PubMed:9571255}.
FT                                /FTId=VAR_008668.
FT   VARIANT     501    501       S -> P (in HHF6; dbSNP:rs121909732).
FT                                {ECO:0000269|PubMed:9571255}.
FT                                /FTId=VAR_008669.
FT   VARIANT     507    507       H -> Y (in HHF6; abolishes inhibition by
FT                                ATP; no effect on activation by ADP;
FT                                dbSNP:rs121909730).
FT                                {ECO:0000269|PubMed:11254391,
FT                                ECO:0000269|PubMed:11903050,
FT                                ECO:0000269|PubMed:9571255}.
FT                                /FTId=VAR_008670.
FT   MUTAGEN     501    501       S->A: Reduces activity and inhibition by
FT                                GTP. {ECO:0000269|PubMed:11903050}.
FT   MUTAGEN     507    507       H->A: Strongly reduces inhibition by GTP.
FT   MUTAGEN     516    516       R->A: Abolishes activation by ADP.
FT                                {ECO:0000269|PubMed:11903050}.
FT   HELIX        66     90       {ECO:0000244|PDB:1L1F}.
FT   HELIX        91     93       {ECO:0000244|PDB:1L1F}.
FT   HELIX        95     97       {ECO:0000244|PDB:1L1F}.
FT   HELIX        99    102       {ECO:0000244|PDB:1L1F}.
FT   HELIX       104    109       {ECO:0000244|PDB:1L1F}.
FT   STRAND      113    123       {ECO:0000244|PDB:1L1F}.
FT   STRAND      125    127       {ECO:0000244|PDB:1L1F}.
FT   STRAND      129    138       {ECO:0000244|PDB:1L1F}.
FT   STRAND      142    152       {ECO:0000244|PDB:1L1F}.
FT   HELIX       158    174       {ECO:0000244|PDB:1L1F}.
FT   STRAND      180    186       {ECO:0000244|PDB:1L1F}.
FT   HELIX       190    192       {ECO:0000244|PDB:1L1F}.
FT   HELIX       195    211       {ECO:0000244|PDB:1L1F}.
FT   TURN        217    219       {ECO:0000244|PDB:1L1F}.
FT   STRAND      220    223       {ECO:0000244|PDB:1L1F}.
FT   HELIX       230    242       {ECO:0000244|PDB:1L1F}.
FT   TURN        243    247       {ECO:0000244|PDB:1L1F}.
FT   HELIX       251    253       {ECO:0000244|PDB:1L1F}.
FT   HELIX       260    262       {ECO:0000244|PDB:1L1F}.
FT   HELIX       271    284       {ECO:0000244|PDB:1L1F}.
FT   HELIX       287    293       {ECO:0000244|PDB:1L1F}.
FT   STRAND      298    300       {ECO:0000244|PDB:1L1F}.
FT   STRAND      303    307       {ECO:0000244|PDB:1L1F}.
FT   HELIX       311    322       {ECO:0000244|PDB:1L1F}.
FT   STRAND      326    331       {ECO:0000244|PDB:1L1F}.
FT   HELIX       345    354       {ECO:0000244|PDB:1L1F}.
FT   STRAND      355    358       {ECO:0000244|PDB:1L1F}.
FT   TURN        371    373       {ECO:0000244|PDB:1L1F}.
FT   STRAND      377    381       {ECO:0000244|PDB:1L1F}.
FT   STRAND      383    386       {ECO:0000244|PDB:1L1F}.
FT   TURN        390    392       {ECO:0000244|PDB:1L1F}.
FT   HELIX       393    395       {ECO:0000244|PDB:1L1F}.
FT   STRAND      399    402       {ECO:0000244|PDB:1L1F}.
FT   STRAND      405    407       {ECO:0000244|PDB:1L1F}.
FT   HELIX       411    419       {ECO:0000244|PDB:1L1F}.
FT   STRAND      423    425       {ECO:0000244|PDB:1L1F}.
FT   HELIX       427    430       {ECO:0000244|PDB:1L1F}.
FT   HELIX       433    447       {ECO:0000244|PDB:1L1F}.
FT   TURN        451    455       {ECO:0000244|PDB:1L1F}.
FT   HELIX       456    475       {ECO:0000244|PDB:1L1F}.
FT   TURN        476    479       {ECO:0000244|PDB:1L1F}.
FT   STRAND      481    484       {ECO:0000244|PDB:1NR1}.
FT   HELIX       491    498       {ECO:0000244|PDB:1L1F}.
FT   HELIX       502    527       {ECO:0000244|PDB:1L1F}.
FT   HELIX       534    551       {ECO:0000244|PDB:1L1F}.
SQ   SEQUENCE   558 AA;  61398 MW;  A7319A840F57FBB2 CRC64;
     MYRYLGEALL LSRAGPAALG SASADSAALL GWARGQPAAA PQPGLALAAR RHYSEAVADR
     EDDPNFFKMV EGFFDRGASI VEDKLVEDLR TRESEEQKRN RVRGILRIIK PCNHVLSLSF
     PIRRDDGSWE VIEGYRAQHS QHRTPCKGGI RYSTDVSVDE VKALASLMTY KCAVVDVPFG
     GAKAGVKINP KNYTDNELEK ITRRFTMELA KKGFIGPGID VPAPDMSTGE REMSWIADTY
     ASTIGHYDIN AHACVTGKPI SQGGIHGRIS ATGRGVFHGI ENFINEASYM SILGMTPGFG
     DKTFVVQGFG NVGLHSMRYL HRFGAKCIAV GESDGSIWNP DGIDPKELED FKLQHGSILG
     FPKAKPYEGS ILEADCDILI PAASEKQLTK SNAPRVKAKI IAEGANGPTT PEADKIFLER
     NIMVIPDLYL NAGGVTVSYF EWLKNLNHVS YGRLTFKYER DSNYHLLMSV QESLERKFGK
     HGGTIPIVPT AEFQDRISGA SEKDIVHSGL AYTMERSARQ IMRTAMKYNL GLDLRTAAYV
     NAIEKVFKVY NEAGVTFT
//
